Biotech is gathering pace: AI systems are simulating novel materials, new genomic technologies are enabling precision bioengineering, and automation is executing production on a massive scale. Softbank Vision Fund Senior Managing Partner, Deep Nishar tells Azeem Azhar why biotech is the next trillion-dollar market, and what breakthroughs to expect.

In this episode they also discuss:

• Why emerging biotech and AI, together, would help control and stop coronavirus-like outbreaks in the future.
• What new materials and medicines are coming out of the “virtuous cycle” of research and funding that is now taking off.
• What the rest of the world should learn from China’s vigorous development of AI technologies.

Further reading:

• “As Zymergen Buys EnEvolv, Biological Manufacturing Is Ready To Transform How Industry Makes Everything From Airplanes To Air Jordans” (Forbes, 2020)
• “AI just found a new type of antibiotics” (Vox, 2020)

@deepnishar

Exponential View newsletter